HuGE Literature Finder
Records
1
-
8
Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance). Pharmacogenetics and genomics 2021 Jun . Patel Jai N, Jiang Chen, Owzar Kouros, Mulkey Flora, Luzum Jasmine A, Mamon Harvey J, Haller Daniel G, Dragovich Tomislav, Alberts Steven R, Bjarnason Georg, Willet Christopher G, Niedzwiecki Donna, Enzinger Peter, Ratain Mark J, Fuchs Charles, McLeod Howard |
Uridine Glucuronosyltransferase 2B7 Polymorphism-Based Pharmacogenetic Dosing of Epirubicin in FEC Chemotherapy for Early-Stage Breast Cancer. Clinical breast cancer 2021 Mar . Joy Anil A, Vos Larissa J, Pituskin Edith, Cook Sarah F, Bies Robert R, Vlahadamis Ann, King Karen, Basi Sanraj K, Meza-Junco Judith, Mackey John R, Stanislaus Avalyn, Damaraju Vijaya L, Damaraju Sambasivarao, Sawyer Michael |
Mycophenolate mofetil-related leukopenia in children and young adults following kidney transplantation: Influence of genes and drugs. Pediatric transplantation 2017 Sep . Varnell Charles D, Fukuda Tsuyoshi, Kirby Cassie L, Martin Lisa J, Warshaw Barry L, Patel Hiren P, Chand Deepa H, Barletta Gina-Marie, Van Why Scott K, VanDeVoorde Rene G, Weaver Donald J, Wilson Amy, Verghese Priya S, Vinks Alexander A, Greenbaum Larry A, Goebel Jens, Hooper David |
A Uridine Glucuronosyltransferase 2B7 Polymorphism Predicts Epirubicin Clearance and Outcomes in Early-Stage Breast Cancer. Clinical breast cancer 2015 Sep . Sawyer Michael B, Pituskin Edith, Damaraju Sambasivarao, Bies Robert R, Vos Larissa J, Prado Carla M M, Kuzma Michelle, Scarfe Andrew G, Clemons Mark, Tonkin Katia, Au Heather-Jane, Koski Sheryl, Joy Anil A, Smylie Michael, King Karen, Carandang Diana, Damaraju Vijaya L, Hanson John, Cass Carol E, Mackey John |
Associations between polymorphisms in target, metabolism, or transport proteins of mycophenolate sodium and therapeutic or adverse effects in kidney transplant patients. Pharmacogenetics and genomics 2014 May 24 (5): 256-62. Woillard Jean-Baptiste, Picard Nicolas, Thierry Antoine, Touchard Guy, Marquet Pierre, |
Uridine diphosphate glucuronosyltransferase 2B7 variant p.His268Tyr as a predictor of kidney allograft early acute rejection. Transplantation proceedings 2013 May 45 (4): 1516-9. Pazik J, O?dak M, Lewandowski Z, Podgórska M, Sitarek E, P?oski R, Ga?azka Z, Kwiatkowski A, Malejczyk J, Durlik |
Pharmacogenetic impact of UDP-glucuronosyltransferase metabolic pathway and multidrug resistance-associated protein 2 transport pathway on mycophenolic acid in thoracic transplant recipients: an exploratory study. Pharmacotherapy 2010 Nov 30 (11): 1097-108. Ting Lillian S L, Benoit-Biancamano Marie-Odile, Bernard Olivier, Riggs K Wayne, Guillemette Chantal, Ensom Mary H |
UGT genotype may contribute to adverse events following medication with mycophenolate mofetil in pediatric kidney transplant recipients. Clinical pharmacology and therapeutics 2009 May 85 (5): 495-500. Prausa S E, Fukuda T, Maseck D, Curtsinger K L, Liu C, Zhang K, Nick T G, Sherbotie J R, Ellis E N, Goebel J, Vinks A |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 26, 2022
- Content source: